Radiation therapy using a simultaneously integrated boost for early-stage breast cancer

Future Oncology

Volumn 3, Issue 5, 2007, Pages 509-513

  Hurkmans, Coen ^a  

^a CATHARINA HOSPITAL   (Netherlands)

Author keywords

Breast radiotherapy; Intensity modulated radiotherapy; Inverse planning; Simultaneous integrated boost

Indexed keywords

ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; EARLY CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RECURRENCE RISK; RISK REDUCTION; SKIN TOXICITY; TREATMENT PLANNING;

EID: 35349012229     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/14796694.3.5.509     Document Type: Article

References (31)

1. van da Laan HP, Dolsma WV, Maduro JH et al.: Three-dimensional conformal simultaneously integrated boost technique for breast-conserving radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 68, 1018-1023 (2007).
2. Fisher B, Anderson S, Redmond CK et al.: Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N. Engl. J. Med. 333, 1456-1461 (1995).
3. Liljegren G, Holmberg L, Bergh J et al.: 10-year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J. Clin. Oncol. 17, 2326-2333 (1999).
4. Forrest AP, Stewart HJ, Everington D et al.: Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. Lancet 348, 708-713 (1996).
5. Singla R, King S, Albuquerque K, Creech S, Dogan N: Simultaneous-integrated boost intensity-modulated. radiation therapy (SIBIMRT) in the treatment of early-stage left-sided breast carcinoma. Med. Dosimetry 31, 190-196 (2006).
6. Bartelink H, Horiot JC, Poortmans PM et al.: Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J. Clin. Oncol. 25, 3259-3265 (2007).
7. Guerrero M, Li XA, Earl MA, Sarfaraz M, Kiggundu E: Simultaneous integrated boost for breast cancer using IMRT: a radiobiological and treatment planning study. Int. J. Radiat. Oncol. Biol. Phys. 59, 1513-1522 (2004).
8. Hurkmans CW, Meijer GJ, van Vliet-Vroegindeweij C, van der Sangen MJ, Cassee J: High-dose simultaneously integrated breast boost using intensity-modulated radiotherapy and inverse optimization. Int. J. Radiat. Oncol. Biol. Phys. 66, 923-930 (2006).
9. Lu H, Cash E, Chen MH et al.: Reduction of cardiac volume in left-breast treatment fields by respiratory maneuvers: a CT study. Int. J. Radiat. Oncol. Biol. Phys. 47, 895-904 (2000).
10. Remouchamps VM, Vicini FA, Sharpe MB et al.: Significant reductions in heart and lung doses using deep inspiration breath hold with active breathing control and intensity-modulated radiation therapy for patients treated with locoregional breast irradiation. Int. J. Radiat. Oncol. Biol. Phys. 55, 392-406 (2003).
11. Korreman SS, Pedersen AN, Aarup LR et al.: Reduction of cardiac and pulmonary complication probabilities after breathing adapted radiotherapy for breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 65, 1375-1380 (2006).
12. Freedman GM, Anderson PR, Li J et al.: Intensity modulated radiation therapy (IMRT) decreases acute skin toxicity for women receiving radiation for breast cancer. Am. J. Clin. Oncol. 29, 66-70 (2006).
13. Vicini FA, Sharpe M, Kestin L et al.: Optimizing breast cancer treatment efficacy with intensity-modulated radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 54, 1336-1344 (2002).
14. Donovan E, Bleakley N, Denholm E et al.: Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiother. Oncol. 82, 254-264 (2007).
15. Harsolia A, Kestin L, Grills I et al.: Intensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 68, 1375-1380 (2007).
16. Borghero YO, Salehpour M, McNeese MD et al.: Multileaf field-in-field forward-planned intensity-modulated dose compensation for whole-breast irradiation is associated with reduced contralateral breast dose: a phantom model comparison. Radiother. Oncol. 82, 324-328 (2007).
17. Landis DM, Luo W, Song J et al.: Variability among breast radiation oncologists in delineation of the postsurgical lumpectomy cavity. Int. J. Radiat. Oncol. Biol. Phys. 67, 1299-1308 (2007).
18. Struikmans H, Warlam-Rodenhuis C, Stam T et al. Interobserver variability of clinical target volume delineation of glandular breast tissue and of boost volume in tangential breast irradiation. Radiother. Oncol. 76, 293-299 (2005).
19. Hurkmans CW, Remeijer P, Lebesque JV, Mijnheer BJ: Set-up verification using portal imaging; review of current clinical practice. Radiother. Oncol. 58, 105-120 (2001).
20. Venables K, Miles EA, Hoskin PJ, Aird EG: Verification films: a study of the daily and weekly reproducibility of breast patient set-up in the START trial. Clin. Oncol. (R. Coll. Radiol.) 17, 337-342 (2005).
21. Jacobson G, Betts V, Smith B: Change in volume of lumpectomy cavity during external-beam irradiation of the intact breast. Int. J. Radiat. Oncol. Biol. Phys. 65, 1161-1164 (2006).
22. Oh KS, Kong FM, Griffith KA, Yanke B, Pierce LJ: Planning the breast tumor bed boost: changes in the excision cavity volume and surgical scar location after breast-conserving surgery and whole breast irradiation. Int. J. Radiat. Oncol. Biol. Phys. 66, 680-686 (2006).
23. Huh SJ, Han Y, Park W, Yang JH: Interfractional dose variation due to seromas in radiotherapy of breast cancer. Med. Desim. 30, 8-11 (2005).
24. Ott OJ, Hildebrandt G, Potter R et al.: Accelerated partial breast irradiation with multi-catheter brachytherapy: local control, side effects and cosmetic-outcome for 274 patients. Results of the German-Austrian multi-centre trial. Radiother. Oncol. 82, 281-286 (2007).
25. Benitez PR. Streeter O, Vicini F et al.: Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a Phase II clinical study. Am. J. Surg. 192, 427-433 (2006).
26. Jeruss JS, Vicini FA, Beitsch PD et al.: Initial outcomes for patients treated on the American Society of Breast Surgeons MammoSite clinical trial for ductal carcinoma-in-situ of the breast. Ann. Surg. Oncol. 13, 967-976 (2006).
27. Vicini F, Winter K, Straube W et al.: A Phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for Stage I/II breast carcinoma: initial report of feasibility and reproductibility of Radiation Therapy Oncology Group (RTOG) Study 0319. Int. J. Radiat. Oncol. Biol. Phys. 63, 1531-1537 (2005).
28. Lovey K, Fodor J, Major T et al.: Fat necrosis after partial-breast irradiation with brachytherapy or electron irradiation versus standard whole-breast radiotherapy - 4-year results of a randomized trial. Int. J. Radiat. Oncol. Biol. Phys. (2007) (In Press).
29. Kuske RR, Winter K, Arthur DW et al.: Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: toxicity analysis of RTOG 95-17. Int. J. Radiat. Oncol. Biol. Phys. 65, 45-51 (2006).
30. Beal K, McCormick B, Zelefsky MJ et al.: Single-fraction intraoperative radiotherapy for breast cancer: early cosmetic results. Int. J. Radiat. Oncol. Biol. Phys. 69, 19-24 (2007).
31. Bartelink H, Boersma LJ, Leer JW, Poortmans P: Radiation dose intensity study in breast cancer in young women: a randomized Phase III trial of additional dose to the tumor bed. YOUNG BOOST trial. 6-8-2004. Trial number BOOG 2004-01, CKTO 2003-13.